Literature DB >> 23787696

How independent are TSE agents from their hosts?

Robert A Somerville1.   

Abstract

Central to understanding the nature TSE agents (or prions) is how their genetic information is distinguished from the host. Are TSEs truly infectious diseases with host-independent genomes, or are they aberrations of a host component derived from the host genome? Recent experiments tested whether glycosylation of host PrP affects TSE strain characteristics. Wild-type mice were infected with 3 TSE strains passaged through transgenic mice with PrP devoid of glycans at 1 or both N-glycosylation sites. Strain-specific characteristics of 1 TSE strain changed but did not change for 2 others. Changes resulted from the selection of mutant TSE strains in a novel replicative environment. In general the properties of established TSEs support the genetic independence of TSE agents from the host, and specifically the primary structure of PrP does not directly encode TSE agent properties. However sporadic TSEs, challenge this independency. The prion hypothesis explains emerging TSEs relatively successfully but poorly accounts for the diversity and mutability of established TSE strains, or how many different infectious conformations are sustained thermodynamically. Research on early changes in RNA expression and events at the ribosome may inform the debate on TSE agent properties and their interaction with host cell machinery.

Entities:  

Keywords:  TSE agents; genetic information; glycosylation; infectious disease; mutability; prion hypothesis

Mesh:

Substances:

Year:  2013        PMID: 23787696      PMCID: PMC3904310          DOI: 10.4161/pri.25420

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  30 in total

1.  Scrapie: a transmissible hereditary disease of sheep.

Authors:  H B PARRY
Journal:  Nature       Date:  1960-02-13       Impact factor: 49.962

Review 2.  A virus behind the mask of prions?

Authors:  Laura Manuelidis
Journal:  Folia Neuropathol       Date:  2004       Impact factor: 2.038

3.  Characterization of the effect of heat on agent strains of the transmissible spongiform encephalopathies.

Authors:  Robert A Somerville; Nicola Gentles
Journal:  J Gen Virol       Date:  2011-04-06       Impact factor: 3.891

4.  Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections.

Authors:  Erdmute Neuendorf; Artur Weber; Armin Saalmueller; Hermann Schatzl; Kurt Reifenberg; Eberhardt Pfaff; Martin Hermann Groschup
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

5.  The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition.

Authors:  Yanhong Pang; Sriram Kurella; Cécile Voisset; Dibyendu Samanta; Debapriya Banerjee; Ariane Schabe; Chanchal Das Gupta; Hervé Galons; Marc Blondel; Suparna Sanyal
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

6.  Post-translational changes to PrP alter transmissible spongiform encephalopathy strain properties.

Authors:  Enrico Cancellotti; Sukhvir P Mahal; Robert Somerville; Abigail Diack; Deborah Brown; Pedro Piccardo; Charles Weissmann; Jean C Manson
Journal:  EMBO J       Date:  2013-02-08       Impact factor: 11.598

7.  Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice.

Authors:  Anna Majer; Sarah J Medina; Yulian Niu; Bernard Abrenica; Kathy J Manguiat; Kathy L Frost; Clark S Philipson; Debra L Sorensen; Stephanie A Booth
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

8.  Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.

Authors:  Déborah Tribouillard-Tanvier; Vincent Béringue; Nathalie Desban; Fabienne Gug; Stéphane Bach; Cécile Voisset; Hervé Galons; Hubert Laude; Didier Vilette; Marc Blondel
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

9.  Host PrP glycosylation: a major factor determining the outcome of prion infection.

Authors:  Nadia L Tuzi; Enrico Cancellotti; Herbert Baybutt; Lorraine Blackford; Barry Bradford; Chris Plinston; Anne Coghill; Patricia Hart; Pedro Piccardo; Rona M Barron; Jean C Manson
Journal:  PLoS Biol       Date:  2008-04-15       Impact factor: 8.029

10.  Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.

Authors:  Déborah Tribouillard-Tanvier; Suzana Dos Reis; Fabienne Gug; Cécile Voisset; Vincent Béringue; Raimon Sabate; Ema Kikovska; Nicolas Talarek; Stéphane Bach; Chenhui Huang; Nathalie Desban; Sven J Saupe; Surachai Supattapone; Jean-Yves Thuret; Stéphane Chédin; Didier Vilette; Hervé Galons; Suparna Sanyal; Marc Blondel
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.